Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Indication
Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (as monotherapy or as adjunctive therapy to beta-blockers).
Therapeutic Area
Eye
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
0.3mg/mL single-dose eye drops
Comments
March 2013 - Not included in the LJF because NHS Lothian decision is that the medicine does not represent sufficient added benefit to other comparator medicines to treat the condition in question which are already available in the formulary. July 2019 (as per LJF) - Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines.
Link to Advice
Advice Published
11/03/2013
SMC Submission Type
Abbreviated
SMC Status
Restricted